MediPharm Labs Corp.
LABS.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.80M | 6.00M | 8.25M | 9.94M | 12.03M |
| Total Receivables | 5.88M | 5.42M | 5.22M | 4.95M | 4.54M |
| Inventory | 6.69M | 7.25M | 5.95M | 6.70M | 6.93M |
| Prepaid Expenses | 538.90K | 121.80K | 294.70K | 495.90K | 630.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 728.80K | 3.33M | 3.27M | 3.50M | 3.57M |
| Total Current Assets | 21.64M | 22.13M | 22.99M | 25.59M | 27.71M |
|
|
|||||
| Total Current Assets | 21.64M | 22.13M | 22.99M | 25.59M | 27.71M |
| Net Property, Plant & Equipment | 13.56M | 13.09M | 13.32M | 14.53M | 14.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 560.20K | 562.80K | 593.50K | 664.70K | 689.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 395.20K | 441.80K | 441.30K | 553.70K | 661.20K |
| Total Assets | 36.15M | 36.22M | 37.34M | 41.34M | 43.72M |
|
|
|||||
| Total Accounts Payable | 3.38M | 3.40M | 2.94M | 2.60M | 1.94M |
| Total Accrued Expenses | 2.08M | 1.51M | 3.12M | 3.80M | 3.98M |
| Short-term Debt | 329.90K | 9.70K | 179.30K | 422.70K | 1.98M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 60.10K | 55.70K | 54.90K | 35.50K | 38.00K |
| Total Finance Division Other Current Liabilities | 1.10M | 1.15M | 995.90K | 1.11M | 967.40K |
| Total Other Current Liabilities | 1.10M | 1.15M | 995.90K | 1.11M | 967.40K |
| Total Current Liabilities | 6.95M | 6.13M | 7.29M | 7.96M | 8.90M |
|
|
|||||
| Total Current Liabilities | 6.95M | 6.13M | 7.29M | 7.96M | 8.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 329.90K | 9.70K | 179.30K | 422.70K | 1.98M |
| Capital Leases | 7.30K | 21.60K | 35.40K | 25.90K | 34.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.96M | 6.15M | 7.33M | 7.99M | 8.94M |
|
|
|||||
| Common Stock & APIC | 147.84M | 139.99M | 139.84M | 148.75M | 146.82M |
| Retained Earnings | -136.74M | -130.67M | -130.26M | -137.46M | -133.65M |
| Treasury Stock & Other | 18.09M | 20.75M | 20.43M | 22.06M | 21.62M |
| Total Common Equity | 29.19M | 30.08M | 30.01M | 33.35M | 34.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.19M | 30.08M | 30.01M | 33.35M | 34.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.19M | 30.08M | 30.01M | 33.35M | 34.79M |
|
|
|||||